炎症性肠病结局的社会决定因素
基于加拿大曼尼托巴省9298例炎症性肠病(IBD)人群队列(1995年4月1日至2018年3月31日),研究低社会经济地位(LSS)对结局的影响。结果显示LSS与更高的门诊就诊、住院、ICU入住、大剂量糖皮质激素使用、麻醉药品和精神药物使用及死亡风险相关,且克罗恩病受影响大于溃疡性结肠炎。作者认为诊断时应高度考虑并处理健康的社会决定因素。
要点
- 低社会经济地位与IBD患者住院(RR=1.38)、ICU入住(RR=1.94)和死亡(HR=1.53)风险升高相关。
- 低社会经济地位者麻醉药品(RR=2.17)和精神药物(RR=1.98)使用增加。
- 低社会经济地位的影响在克罗恩病患者中大于溃疡性结肠炎患者。
核心结论
- 低社会经济地位与炎症性肠病患者更差的结局相关。
- 作者认为诊断时应高度考虑并处理健康的社会决定因素。
研究设计与样本
- 基于人群的炎症性肠病队列研究,纳入1995年4月1日至2018年3月31日曼尼托巴省所有9298例居民患者。
- 通过经过验证的病例定义从曼尼托巴省健康行政数据库识别患者,并链接就业与收入援助及儿童与家庭服务数据库。
- 低社会经济地位定义为曾注册就业与收入援助或儿童与家庭服务,或处于地区层面社会经济地位最低五分位。
主要发现
- 低社会经济地位组较无任何低社会经济地位标志组,年度门诊就诊率升高(RR=1.10,95%CI 1.06-1.13)。
- 低社会经济地位组较无标志组住院率升高(RR=1.38,95%CI 1.31-1.44),ICU入住率升高(RR=1.94,95%CI 1.65-2.27)。
- 低社会经济地位组较无标志组使用泼尼松等效剂量>2000 mg/年者增多(RR=1.12,95%CI 1.03-1.21),死亡风险升高(HR=1.53,95%CI 1.36-1.73)。
- 低社会经济地位组较无标志组麻醉药品使用增多(RR=2.17,95%CI 2.01-2.34),精神药物使用增多(RR=1.98,95%CI 1.84-2.13)。
- 低社会经济地位的影响在克罗恩病患者中大于溃疡性结肠炎患者。
临床怎么用
- 作者认为诊断时应高度考虑并处理健康的社会决定因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In a population-based inflammatory bowel disease (IBD) cohort, we aimed to determine whether having lower socioeconomic status (LSS) impacted on outcomes. METHODS: We identified all 9,298 Manitoba residents with IBD from April 1, 1995, to March 31, 2018 by applying a validated case definition to the Manitoba Health administrative database. We could identify all outpatient physician visits, hospitalizations, surgeries, intensive care unit admissions, and prescription medications. Their data were linked with 2 Manitoba databases, one identifying all persons who received Employment and Income Assistance and another identifying all persons with Child and Family Services contact. Area-level socioeconomic status was defined by a factor score incorporating average household income, single parent households, unemployment rate, and high school education rate. LSS was identified by any of ever being registered for Employment and Income Assistance or with Child and Family Services or being in the lowest area-level socioeconomic status quintile. RESULTS: Comparing persons with LSS vs those without any markers of LSS, there were increased rates of annual outpatient physician visits (relative risk [RR] = 1.10, 95% confidence interval [CI] = 1.06-1.13), hospitalizations (RR = 1.38, 95% CI = 1.31-1.44), intensive care unit admission (RR = 1.94, 95% CI = 1.65-2.27), use of corticosteroids >2,000 mg/yr (RR = 1.12, 95% CI = 1.03-1.21), and death (hazard ratio 1.53, 95% CI = 1.36-1.73). Narcotics (RR = 2.17, 95% CI = 2.01-2.34) and psychotropic medication use (RR = 1.98, 95% CI = 1.84-2.13) were increased. The impact of LSS was greater for those with Crohn's disease than for those with ulcerative colitis. DISCUSSION: LSS was associated with worse outcomes in persons with IBD. Social determinants of health at time of diagnosis should be highly considered and addressed.
引用
- Bernstein CN, Walld R, Marrie RA, et al. Social Determinants of Outcomes in Inflammatory Bowel Disease. Am J Gastroenterol. 2020. PMID: 32769424. doi:10.14309/ajg.0000000000000794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。